64 related articles for article (PubMed ID: 9157737)
21. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
[TBL] [Abstract][Full Text] [Related]
22. Initiating insulin treatment in insulin-requiring type 2 diabetic patients: comparative efficiency and cost of outpatient and inpatient management. INNOV Study Group.
Penfornis A; Millot L
Diabetes Metab; 1998 Apr; 24(2):137-42. PubMed ID: 9592638
[TBL] [Abstract][Full Text] [Related]
23. [Will prescribing all types of insulin no longer be allowed?].
Schmidt K
MMW Fortschr Med; 2006 Mar; 148(10):44-6. PubMed ID: 16612950
[No Abstract] [Full Text] [Related]
24. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study.
Liebl A; Breitscheidel L; Nicolay C; Happich M
Curr Med Res Opin; 2008 Aug; 24(8):2349-58. PubMed ID: 18606055
[TBL] [Abstract][Full Text] [Related]
25. Are Type 2 diabetic patients offered adequate foot care? The role of physician and patient characteristics.
De Berardis G; Pellegrini F; Franciosi M; Belfiglio M; Di Nardo B; Greenfield S; Kaplan SH; Rossi MC; Sacco M; Tognoni G; Valentini M; Nicolucci A;
J Diabetes Complications; 2005; 19(6):319-27. PubMed ID: 16260348
[TBL] [Abstract][Full Text] [Related]
26. [Differences between diabetes mellitus type 2 patients switched and not switched over to insulin treatment after specialist consultation].
Goddijn PP; Meyboom-de Jong B; Feskens EJ; van Ballegooie E; Bilo HJ
Ned Tijdschr Geneeskd; 1998 May; 142(18):1023-6. PubMed ID: 9623204
[TBL] [Abstract][Full Text] [Related]
27. [Insulin therapy in type 2 diabetes. Insured patients would be willing to pay for added benefits].
MMW Fortschr Med; 2008 Dec; 150(49-50):56-7. PubMed ID: 19133372
[No Abstract] [Full Text] [Related]
28. Economic evaluation of the treatment of type 2 diabetes with insulin glargine based on the LAPTOP trial.
Janka HU; Högy B
Eur J Health Econ; 2008 May; 9(2):165-70. PubMed ID: 17530309
[TBL] [Abstract][Full Text] [Related]
29. [Cost-benefit analysis of education programs and of treatment in type 2 diabetes].
Jörgens V
Diabete Metab; 1993 Dec; 19(5 Suppl):510-3. PubMed ID: 8206189
[TBL] [Abstract][Full Text] [Related]
30. [The pharmacotherapy circle--a promising way for improving quality in primary medical care].
Bausch J
Z Arztl Fortbild (Jena); 1995 Aug; 89(4):406-14. PubMed ID: 7571744
[TBL] [Abstract][Full Text] [Related]
31. [Significance of the specialized treatment clinic for the rehabilitation of diabetic patients].
Ledermann H; Adam S; Schaffner O
Rehabilitation (Stuttg); 1988 Aug; 27(3):166-9. PubMed ID: 3175321
[TBL] [Abstract][Full Text] [Related]
32. [Disease management programs: data for the waste bin?].
Martin S
Dtsch Med Wochenschr; 2014 Jan; 139(1-2):17-8. PubMed ID: 24062020
[No Abstract] [Full Text] [Related]
33. Three years' experience after national introduction of teaching programs for type II diabetic patients in Germany: how to train general practitioners.
Joergens V; Gruesser M
Patient Educ Couns; 1995 Sep; 26(1-3):195-202. PubMed ID: 7494722
[TBL] [Abstract][Full Text] [Related]
34. Structured patient education for out-patients with hypertension in general practice: a model project in Germany.
Gruesser M; Hartmann P; Schlottmann N; Lohmann FW; Sawicki PT; Joergens V
J Hum Hypertens; 1997 Aug; 11(8):501-6. PubMed ID: 9322831
[TBL] [Abstract][Full Text] [Related]
35. Health care for persons with non-insulin-dependent diabetes mellitus. The German experience.
Berger M; Jörgens V; Flatten G
Ann Intern Med; 1996 Jan; 124(1 Pt 2):153-5. PubMed ID: 8554209
[TBL] [Abstract][Full Text] [Related]
36. [Germans have an unhealthy life style. How family physicians can make improvements].
MMW Fortschr Med; 2009 Sep; 151(36):10. PubMed ID: 19813531
[No Abstract] [Full Text] [Related]
37. Changing care patterns. Diabetic education: cost effectiveness need not reduce quality care.
Flint E
Australas Nurses J; 1980; 9(3):1, 3. PubMed ID: 6770808
[No Abstract] [Full Text] [Related]
38. [Dissemination of Patient Education in the Rehabilitation of Chronic Back Pain - Cost Analysis of a Program Implementation].
Neusser S; Ivancevic S; Biermann J; Meng K; Faller H; Wasem J; Neumann A
Rehabilitation (Stuttg); 2017 Oct; 56(5):305-312. PubMed ID: 28482369
[TBL] [Abstract][Full Text] [Related]
39. [Insulin pens are no longer in reference price groups: Geriatric patients are not included!].
Schröder F; Zeyfang A
Z Gerontol Geriatr; 2014 Dec; 47(8):700. PubMed ID: 25412804
[No Abstract] [Full Text] [Related]
40. [Which patients are (not) included in the DMP diabetes programme?].
Dunkelberg S; Zingel D; Noack A; van den Bussche H; Kaduszkiewicz H
Gesundheitswesen; 2006 May; 68(5):289-93. PubMed ID: 16773549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
